April 3, 2024 • 7:00 AM EDT Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
March 27, 2024 • 9:00 AM EDT Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab